Genetic Link Between MYBPC3 Deletion and Heart Dysfunction in CAD Patients
Author Information
Author(s): Anshika Srivastava, Naveen Garg, Tulika Mittal, Roopali Khanna, Shipra Gupta, Prahlad Kishore Seth, Balraj Mittal
Primary Institution: Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India
Hypothesis
Does the MYBPC3 25 bp deletion polymorphism influence left ventricular dysfunction in coronary artery disease patients?
Conclusion
The MYBPC3 25 bp deletion is associated with compromised left ventricular ejection fraction in coronary artery disease patients.
Supporting Evidence
- The study found that 25.9% of CAD patients had compromised ejection fractions.
- The presence of the MYBPC3 deletion was significantly associated with lower left ventricular ejection fraction.
- Replication studies confirmed the association of MYBPC3 deletion with compromised ejection fraction.
Takeaway
Some people with heart disease have a genetic change that makes their heart work less well. This study found that this change is common in certain patients.
Methodology
The study analyzed 265 CAD patients and 220 controls, using polymerase chain reaction to determine MYBPC3 25 bp polymorphism.
Potential Biases
Possible linkage disequilibrium with neighboring genes may confound results.
Limitations
The sample size is limited, and the study is retrospective, requiring confirmation in larger cohorts.
Participant Demographics
The study included 405 CAD patients, with a mean age of approximately 55.78 years, and a male predominance (85.9%).
Statistical Information
P-Value
<0.001
Confidence Interval
OR 4.49 (1.58 – 11.82)
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website